TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29026385

Group type: EXPERIMENTAL
Intervention: Ketamine infusion (0.1mg/kg bolus followed by 2ug/kg/min infusion)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Saline infusion (physiological saline bolus followed by saline infusion)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Ketamine infusion
Number of subjects: 46

Group type: COMPARATOR
Intervention: Ketamine infusion and Saline infusion
Number of subjects: 46
Study: 25940554

Group type: EXPERIMENTAL
Intervention: 0.1 mg/ml mitomycin-C (MMC) applied for 1 min
Number of subjects: 50

Group type: COMPARATOR
Intervention: 0.2 mg/ml mitomycin-C (MMC) applied for 1 min
Number of subjects: 50
Study: 23168285

Group type: EXPERIMENTAL
Intervention: Niacin
Number of subjects: 407

Group type: COMPARATOR
Intervention: Control (no niacin)
Number of subjects: 407
Study: 21307015

Group type: EXPERIMENTAL
Intervention: Harmonic Focus (HF)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control
Number of subjects: 92
Study: 19852811

Group type: EXPERIMENTAL
Intervention: Daily SMS reminders
Number of subjects: 424

Group type: COMPARATOR
Intervention: Control group (no SMS reminders)
Number of subjects: 424
Study: 16333854

Group type: EXPERIMENTAL
Intervention: PSA velocity > 0.0 ng/mL per month
Number of subjects: 213

Group type: COMPARATOR
Intervention: PSA velocity <= 0.0 ng/mL per month
Number of subjects: 213
Study: 15300656

Group type: EXPERIMENTAL
Intervention: Rasagiline 1 mg/day
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Rasagiline 2 mg/day
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Rasagiline 4 mg/day
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Rasagiline (all doses combined)
Number of subjects: 56
Study: 10408537

Group type: EXPERIMENTAL
Intervention: Interferon beta‐1a (IFN‐beta) 3 MIU for 2 weeks and then 6 MIU for 10 weeks, subcutaneously three times weekly
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 8786722

Group type: EXPERIMENTAL
Intervention: Moderately energy-restricted diet (80% of habitual intake)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 24
Study: 2276384

Group type: EXPERIMENTAL
Intervention: Alprazolam 2 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ethanol (combined with Alprazolam)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low dose alprazolam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diazepam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 7405924

Group type: EXPERIMENTAL
Intervention: Hydrocortisone retention enemas (Rectoid)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Hydrocortisone retention enemas (Cortenema)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Hydrocortisone retention enemas (Rectoid and Cortenema)
Number of subjects: 12
Study: 30704764

Group type: EXPERIMENTAL
Intervention: Pantoprazole (iron chelator plus pantoprazole)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (iron chelator)
Number of subjects: 60
Study: 28498942

Group type: EXPERIMENTAL
Intervention: 4000 IU vitamin D daily
Number of subjects: 400

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study: 24512248

Group type: EXPERIMENTAL
Intervention: Disgust induction
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Embarrassment induction
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control (no emotion)
Number of subjects: 90
Study: 22805324

Group type: EXPERIMENTAL
Intervention: PSA screening
Number of subjects: 0

Group type: COMPARATOR
Intervention: No screening
Number of subjects: 0
Study: 20230460

Group type: EXPERIMENTAL
Intervention: Aerobic exercise intervention (8-week aerobic conditioning followed by 16-week maintenance)
Number of subjects: 0
Study: 17620494

Group type: EXPERIMENTAL
Intervention: Galantamine (intervention in a randomized, double-blind, placebo-controlled trial)
Number of subjects: 896

Group type: COMPARATOR
Intervention: Placebo (control in a randomized, double-blind, placebo-controlled trial)
Number of subjects: 896
Study: 15567174

Group type: EXPERIMENTAL
Intervention: Combined high-throughput analyses (HTA)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Microarray analysis
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: SAGE and EST analyses
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: RT-PCR validation
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Human Breast Cancer Tissue Profiling Array
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Immunohistochemical staining
Number of subjects: 9
Study: 12000349

Group type: EXPERIMENTAL
Intervention: Oral health care education programme (OHCE)
Number of subjects: 369

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 369
Study: 10446819

Group type: EXPERIMENTAL
Intervention: Motor Activity Assessment Scale (MAAS)
Number of subjects: 25
Study: 7615597

Group type: EXPERIMENTAL
Intervention: Ring polyethylene cementless cup
Number of subjects: 126
Study: 2085969

Group type: EXPERIMENTAL
Intervention: Mifepristone 600 mg single oral dose
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 10246462

Group type: EXPERIMENTAL
Intervention: Health education interventions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Baseline questionnaire and group method for internality training
Number of subjects: 0
Study: 31654645

Group type: EXPERIMENTAL
Intervention: Celecoxib
Number of subjects: 60

Group type: COMPARATOR
Intervention: Acetaminophen
Number of subjects: 60
Study: 31100723

Group type: EXPERIMENTAL
Intervention: Investigational device (Maverick total disc replacement)
Number of subjects: 577

Group type: COMPARATOR
Intervention: Control (anterior lumbar interbody fusion)
Number of subjects: 577
Study: 28869722

Group type: EXPERIMENTAL
Intervention: Ibuprofen 25 mg lozenge
Number of subjects: 385

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 385
Study: 25728546

Group type: EXPERIMENTAL
Intervention: Fentanyl ITS at 170 μA
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Fentanyl ITS at 140 μA
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Fentanyl ITS at 200 μA
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Fentanyl ITS at 230 μA
Number of subjects: 52

Group type: COMPARATOR
Intervention: Intravenous fentanyl citrate
Number of subjects: 52
Study: 25693333

Group type: EXPERIMENTAL
Intervention: Sugammadex 0.5 mg kg‐1
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Sugammadex 8.0 mg kg‐1
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Sugammadex
Number of subjects: 99
Study: 21037268

Group type: EXPERIMENTAL
Intervention: Intrathecal levobupivacaine 6.2 mg (ED₅₀)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Intrathecal levobupivacaine 12.9 mg (ED₉₅)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Combined spinal-epidural anaesthesia with intrathecal morphine 100 µg and intrathecal sufentanil 2.5 µg
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Greater doses of levobupivacaine
Number of subjects: 85
Study: 19418823

Group type: EXPERIMENTAL
Intervention: Anthracycline-containing regimens
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-anthracycline-containing regimens
Number of subjects: 0
Study: 18261363

Group type: EXPERIMENTAL
Intervention: 4 mg rosiglitazone
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 8 mg rosiglitazone
Number of subjects: 12

Group type: COMPARATOR
Intervention: Caucasian subjects (control group)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Japanese subjects
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Korean subjects
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Mainland Chinese subjects
Number of subjects: 12
Study: 16887854

Group type: EXPERIMENTAL
Intervention: Achievement of NCEP LDL-C goal <1.8 mmol/L
Number of subjects: 634

Group type: COMPARATOR
Intervention: Statin regimen intensity
Number of subjects: 634
Study: 15362593

Group type: EXPERIMENTAL
Intervention: Activated charcoal (50 g) with atropine (0.01 mg/kg I.M. administered 15 min prior to acetaminophen ingestion)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Activated charcoal (50 g) alone
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (no activated charcoal or atropine)
Number of subjects: 10
Study: 11115081

Group type: EXPERIMENTAL
Intervention: PEG-hirudin (PEG-Hi) 0.05 mg/kg body weight, single intravenous bolus injection
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: PEG-hirudin (PEG-Hi)
Number of subjects: 38
Study: 8861828

Group type: EXPERIMENTAL
Intervention: Solution of 60 mg/ml paracetamol, 1000 mg dose
Number of subjects: 10

Group type: COMPARATOR
Intervention: Fatty suppository, 1000 mg dose
Number of subjects: 10
Study: 1798005

Group type: EXPERIMENTAL
Intervention: Daytime ambulatory blood pressure measurement
Number of subjects: 318

Group type: COMPARATOR
Intervention: Clinic blood pressure measurement
Number of subjects: 318

Group type: EXPERIMENTAL
Intervention: Electrocardiographic (ECG) voltages
Number of subjects: 318
Study: 6358278

Group type: EXPERIMENTAL
Intervention: Full-spectrum sunlight exposure (1, 2, 3, 6, and 9 sunburn units, approximately 30-270 millijoules/cm2)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: UVA radiation exposure
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Suberythemal dose of UVB or UVA radiation
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Melanin sun protection factor values
Number of subjects: 22
Study: 31601583

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (24 sessions of real acupuncture)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham acupuncture (24 sessions using a placebo needle)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 60
Study: 27402064

Group type: EXPERIMENTAL
Intervention: Lulizumab pegol (IV; 0.01-100 mg)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Lulizumab pegol (SC; 6.25 mg every 2 weeks, 12.5 mg weekly, 37.5 mg weekly)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Lulizumab pegol (IV doses ≥9 mg)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo (IV and SC)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Lulizumab pegol (SAD)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Lulizumab pegol (MAD)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Lulizumab pegol (IV or SC)
Number of subjects: 180
Study: 25439501

Group type: EXPERIMENTAL
Intervention: Facilitated Lifestyle Intervention Prescription (FLIP)
Number of subjects: 59
Study: 25015689

Group type: EXPERIMENTAL
Intervention: Baseline circulating total dpMGP level
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Total dpMGP level in younger patients (age < 57)
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Total dpMGP level in older patients (age ≥ 57)
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Independent correlates of dpMGP level
Number of subjects: 215
Study: 22230419

Group type: EXPERIMENTAL
Intervention: Ischia thermal water nasal aerosol for 15 days per month for three consecutive months
Number of subjects: 40

Group type: COMPARATOR
Intervention: 0.9% NaCl (isotonic) solution
Number of subjects: 40
Study: 19076192

Group type: EXPERIMENTAL
Intervention: 35% glycolic acid (GA) peels
Number of subjects: 44

Group type: COMPARATOR
Intervention: 20% salicylic-10% mandelic acid peels (SMPs)
Number of subjects: 44
Study: 17560135

Group type: EXPERIMENTAL
Intervention: Total-etch adhesive, Prime & Bond NT
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Self-etch adhesive, Xeno III
Number of subjects: 40
Study: 15541411

Group type: EXPERIMENTAL
Intervention: 200 mg oral mifepristone followed by 400 microg oral misoprostol 2 days later
Number of subjects: 321

Group type: EXPERIMENTAL
Intervention: Home use of misoprostol
Number of subjects: 321
Study: 11468134

Group type: EXPERIMENTAL
Intervention: Flupenthixol decanoate (10 mg, i.m. injection every second week for 6 months)
Number of subjects: 281

Group type: COMPARATOR
Intervention: Placebo (i.m. injection every second week for 6 months)
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: Flupenthixol decanoate
Number of subjects: 281
Study: 9746115

Group type: EXPERIMENTAL
Intervention: ET-1 infusion
Number of subjects: 10
Study: 8312508

Group type: EXPERIMENTAL
Intervention: Laser-assisted angioplasty
Number of subjects: 134

Group type: COMPARATOR
Intervention: Conventional balloon angioplasty
Number of subjects: 134
Study: 3170533

Group type: EXPERIMENTAL
Intervention: Fluoridated toothpastes (0.1 ppm F‐ as nicomethanolhydrofluoride, 1100 ppm F‐ as NaF, 1350 ppm F‐ as NaF/MFP)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo toothpaste (0.1 ppm F‐)
Number of subjects: 10
Study: 31236002

Group type: EXPERIMENTAL
Intervention: Early enteral nutrition (EEN)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Delayed enteral nutrition (DEN)
Number of subjects: 53
Study: 27786509

Group type: EXPERIMENTAL
Intervention: Alcohol condition at encoding, immediate retrieval
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Alcohol condition at encoding, 1-week delay retrieval
Number of subjects: 249

Group type: COMPARATOR
Intervention: Sober condition at encoding, immediate retrieval
Number of subjects: 249

Group type: COMPARATOR
Intervention: Placebo condition at encoding, immediate retrieval
Number of subjects: 249

Group type: COMPARATOR
Intervention: Placebo condition at encoding, 1-week delay retrieval
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Intoxicated condition at encoding, immediate retrieval
Number of subjects: 249

Group type: EXPERIMENTAL
Intervention: Intoxicated condition at encoding, 1-week delay retrieval
Number of subjects: 249
Study: 25860108

Group type: EXPERIMENTAL
Intervention: Enhanced referral process including a wallet card and standardized physician monologue
Number of subjects: 202

Group type: COMPARATOR
Intervention: Non-enhanced referral process (control group)
Number of subjects: 202
Study: 24624849

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine infusion (0.2-1.4 microg kg(‐1) per hour)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine infusion
Number of subjects: 28
Study: 21471823

Group type: EXPERIMENTAL
Intervention: Estrogen (0.625 mg conjugated estrogens)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 19585697

Group type: EXPERIMENTAL
Intervention: Stimulating popliteal catheter (STIM group)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Nonstimulating popliteal catheter (NONSTIM group)
Number of subjects: 48
Study: 17364275

Group type: EXPERIMENTAL
Intervention: Metformin 1000 mg bid for 16 weeks
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Metformin 850 mg bid from the first trimester throughout pregnancy
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Metformin treatment in nonpregnant women
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study: 15295655

Group type: EXPERIMENTAL
Intervention: Trehalose eyedrops
Number of subjects: 36

Group type: COMPARATOR
Intervention: Commercially available eyedrops (hyaluronan or hydroxyethylcellulose)
Number of subjects: 36
Study: 12216603

Group type: EXPERIMENTAL
Intervention: Traditional Chinese Acupuncture
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo treatment (mock-TENS)
Number of subjects: 24
Study: 10502902

Group type: EXPERIMENTAL
Intervention: Experimental sessions (orthodontic pain induced by placing orthodontic separators)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control sessions
Number of subjects: 14
Study: 7768078

Group type: EXPERIMENTAL
Intervention: Melatonin (0.3 mg or 1.0 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2322788

Group type: EXPERIMENTAL
Intervention: Double contrast barium enema
Number of subjects: 625

Group type: EXPERIMENTAL
Intervention: Flexible rectosigmoidoscopy
Number of subjects: 625

Group type: EXPERIMENTAL
Intervention: Combined methods (double contrast barium enema and flexible rectosigmoidoscopy)
Number of subjects: 625

Group type: COMPARATOR
Intervention: Control group (negative assessment)
Number of subjects: 625
Study: 232147

Group type: EXPERIMENTAL
Intervention: Tc‐99m pyrophosphate (PPi)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Tc‐99m methylene diphosphonate (MDP)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Comparison of relative intensity with each agent
Number of subjects: 24
Study: 29959852

Group type: EXPERIMENTAL
Intervention: Polymeric protein module added to enteral nutrition (EN) to reach protein goal by day 4
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Oligomeric protein supplementation
Number of subjects: 25

Group type: COMPARATOR
Intervention: Routine enteral nutrition (control)
Number of subjects: 25
Study: 28091703

Group type: EXPERIMENTAL
Intervention: Landiolol (0.1, 0.2, and 0.3 mg/kg BW)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Esmolol (0.5, 1, and 1.5 mg/kg BW)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Landiolol and Esmolol
Number of subjects: 12
Study: 26560483

Group type: EXPERIMENTAL
Intervention: Dexamethasone 1.65 mg
Number of subjects: 49

Group type: COMPARATOR
Intervention: No dexamethasone
Number of subjects: 49
Study: 23726977

Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 21346734

Group type: EXPERIMENTAL
Intervention: Pimozide adjunctive treatment
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 19564531

Group type: EXPERIMENTAL
Intervention: Postrecurrence therapy for early stage colon cancer
Number of subjects: 537

Group type: COMPARATOR
Intervention: Postrecurrence therapy for late stage colon cancer
Number of subjects: 537

Group type: EXPERIMENTAL
Intervention: First detection methods for recurrence in early stage colon cancer
Number of subjects: 537

Group type: COMPARATOR
Intervention: First detection methods for recurrence in late stage colon cancer
Number of subjects: 537

Group type: EXPERIMENTAL
Intervention: Median survival after second surgery after recurrence for early stage
Number of subjects: 537

Group type: COMPARATOR
Intervention: Median survival after second surgery after recurrence for late stage
Number of subjects: 537

Group type: EXPERIMENTAL
Intervention: Recurrence patterns for early stage colon cancer
Number of subjects: 537

Group type: COMPARATOR
Intervention: Recurrence patterns for late stage colon cancer
Number of subjects: 537
Study: 17530377

Group type: EXPERIMENTAL
Intervention: Indication of pain site by finger
Number of subjects: 137

Group type: COMPARATOR
Intervention: Indication of pain site by hand
Number of subjects: 137
Study: 15189478

Group type: EXPERIMENTAL
Intervention: Aerobic training (AT)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Weight training (WT)
Number of subjects: 45

Group type: COMPARATOR
Intervention: No-treatment (NT)
Number of subjects: 45
Study: 11816439

Group type: EXPERIMENTAL
Intervention: Quinine-Clindamycin (QC7)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Artesunate (A7)
Number of subjects: 129
Study: 9501680

Group type: EXPERIMENTAL
Intervention: SAR-A group
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: SAR group
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 73
Study: 8472058

Group type: EXPERIMENTAL
Intervention: Peak Expiratory Flow (PEF)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Absolute decrease in PEF of > or = 70 l.min‐1
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Absolute decrease in PEF of > or = 80 l.min‐1
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: PEF readings
Number of subjects: 150
Study: 3511209

Group type: EXPERIMENTAL
Intervention: 3-week benzathine penicillin G injections
Number of subjects: 179

Group type: COMPARATOR
Intervention: 4-week benzathine penicillin G injections
Number of subjects: 179
Study: 31690523

Group type: EXPERIMENTAL
Intervention: Intermittent vacuum therapy (IVT) at -50 mBar negative pressure, 12 sessions of 30 minutes over 6 weeks.
Number of subjects: 70

Group type: COMPARATOR
Intervention: Sham treatment at -5 mBar negative pressure, 12 sessions of 30 minutes over 6 weeks.
Number of subjects: 70
Study: 31138279

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 48

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 48
Study: 28029852

Group type: EXPERIMENTAL
Intervention: Mindfulness-based weight-loss intervention (n=100)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Control group (Progressive Muscle Relaxation, n=94)
Number of subjects: 194
Study: 26292675

Group type: EXPERIMENTAL
Intervention: LifeLab intervention (includes professional development for teachers, preparatory lessons, hands-on practical day at LifeLab, 'Meet the Scientist' session, post-visit lessons, participation in LifeLab Schools' Conference)
Number of subjects: 2500

Group type: COMPARATOR
Intervention: Control group (schools not receiving the LifeLab intervention)
Number of subjects: 2500
Study: 24107083

Group type: EXPERIMENTAL
Intervention: Children's Healthy Living Program (environmental intervention)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Community assessments in intervention trial communities
Number of subjects: 180

Group type: COMPARATOR
Intervention: Prevalence survey measurements
Number of subjects: 180
Study: 21866660

Group type: EXPERIMENTAL
Intervention: PSS group
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Non-PSS group
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: PSS group and Non-PSS group
Number of subjects: 180
Study: 19712709

Group type: EXPERIMENTAL
Intervention: Neurofeedback training (NF), combined protocol of theta/beta training and slow cortical potentials (SCP) training, 18 units of 50 minutes each
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control training (computerized attention skills training)
Number of subjects: 72
Study: 18218206

Group type: EXPERIMENTAL
Intervention: External positive end-expiratory pressure (PEEPe) at 80% of intrinsic PEEP (PEEPi)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: External positive end-expiratory pressure (PEEPe) at 100% of intrinsic PEEP (PEEPi)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: External positive end-expiratory pressure (PEEPe) at 120% of intrinsic PEEP (PEEPi)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Changes in plateau pressure (Pplat) at different PEEPe levels
Number of subjects: 15
Study: 14688163

Group type: EXPERIMENTAL
Intervention: 150 IU rFSH
Number of subjects: 257

Group type: EXPERIMENTAL
Intervention: 200 IU rFSH
Number of subjects: 257